Expansion of the polyglutamine domain in Ataxin-1 or Parkinson disease-associated missense mutations of α-Synuclein presumably lead to increased levels of the respective proteins, sufficiently high to elicit disease. Here, ATXN1 is linked to Parkinson disease.